Health Outcomes for Clients of Needle and Syringe Programs in Prisons

被引:38
作者
Lazarus, Jeffrey V. [1 ,2 ]
Safreed-Harmon, Kelly [1 ,2 ]
Hetherington, Kristina L. [1 ]
Bromberg, Daniel J. [2 ]
Ocampo, Denise [2 ]
Graf, Niels [3 ]
Dichtl, Anna [3 ]
Stover, Heino [3 ]
Wolff, Hans [4 ,5 ]
机构
[1] Univ Copenhagen, Ctr Excellence Hlth Immun & Infect, Rigshosp, Copenhagen, Denmark
[2] Univ Barcelona, Barcelona Inst Global Hlth, Hosp Clin, Barcelona, Spain
[3] Frankfurt Univ Appl Sci, Inst Addict Res, Frankfurt, Germany
[4] Geneva Univ Hosp, Div Prison Hlth, Geneva, Switzerland
[5] Univ Geneva, Geneva, Switzerland
关键词
bloodborne pathogens; drug use; harm reduction; hepatitis; viral; human; HIV; needle-exchange programs; prisons; review; systematic; HEPATITIS-C VIRUS; HARM REDUCTION; HIV-INFECTION; DRUG-USE; TUBERCULOSIS; PREVENTION; EXCHANGE; TRANSMISSION;
D O I
10.1093/epirev/mxx019
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
High levels of drug dependence have been observed in the prison population globally, and the sharing of injecting drug equipment in prisons has contributed to higher prevalence of bloodborne diseases in prisoners than in the general population. Few prison needle and syringe programs (PNSPs) exist. We conducted a systematic review to assess evidence regarding health outcomes of PNSPs. We searched peer-reviewed databases for data relating to needle and syringe programs in prisons. The search methodology was conducted in accordance with accepted guidelines. Five studies met review inclusion criteria, and all presented evidence associating PNSPs with one or more health benefits, but the strength of the evidence was low. The outcomes for which the studies collectively demonstrated the strongest evidence were prevention of human immunodeficiency virus and viral hepatitis. Few negative consequences from PNSPs were observed, consistent with previous evidence assessments. More research is needed on PNSP effectiveness, and innovative study designs are needed to overcome methodological limitations of previous research. Until stronger evidence becomes available, policymakers are urged to recognize that not implementing PNSPs has the potential to cause considerable harm, in light of what is currently known about the risks and benefits of needle and syringe programs and PNSPs and about the high prevalence of human immunodeficiency virus and viral hepatitis in prisons.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 50 条
[1]  
[Anonymous], CASE STUDIES GLOBAL
[2]  
[Anonymous], DECL LISB RIGHTS PAT
[3]  
[Anonymous], CONS STAT DRUG US PR
[4]  
[Anonymous], 1993, WHO GUID HIV INF AID
[5]  
[Anonymous], HIV HEPATITIS PRAVEN
[6]  
[Anonymous], VIENN DECL ORG END
[7]  
[Anonymous], 2013, GOOD GOV PRIS HLTH 2
[8]  
[Anonymous], HIV PREV TREATM CAR
[9]  
[Anonymous], UNAIDS 2016 2021 STR
[10]  
[Anonymous], REC NO R 93 6